Store
The World Liquid Biopsy Market, 2021
Publication Date: December 28, 2021
Tags: Diagnostic Instruments, Genetic Diseases, Liquid Biopsy, Oncology and Cancer
Pages: 225
SKU: 21-021
Unlock valuable insights and data points for strategic business planning with Kalorama Information’s comprehensive report, The World Liquid Biopsy Market, 2021. This report delves into various facets of the liquid biopsy market, providing a detailed analysis that is crucial for stakeholders in the healthcare and diagnostics industry.
Market Highlights:
- Research vs. Clinical Liquid Biopsy: Examine the differences and applications of liquid biopsy in research and clinical settings.
- Regional Market Analysis: Understand the market dynamics and opportunities for liquid biopsy across different regions.
- Analyte-Specific Markets: Explore the market segmentation by types of analytes, including CTC-based, ctDNA-based, EV and exosome-based, multi-analyte, and other liquid biopsy methods.
In-Depth Market Segmentation:
- CTC-based Liquid Biopsy: Market size and growth trends for circulating tumor cell (CTC) assays.
- ctDNA-based Liquid Biopsy: Insights into the market for circulating tumor DNA (ctDNA) tests.
- EV and Exosome-based Liquid Biopsy: Analysis of the market for extracellular vesicle (EV) and exosome-based liquid biopsy.
- Multi-Analyte-based Liquid Biopsy: Detailed look into tests that assess multiple analytes.
- Other Liquid Biopsy Methods: Overview of additional liquid biopsy techniques and their market potential.
Cancer Type Analysis:
- Liquid Biopsy Market by Type of Cancer: Focused insights on liquid biopsy applications for various cancers, including breast, lung, colorectal, ovarian, prostate, pan-cancer, and others.
Selected Liquid Biopsy Tests:
- ctDNA-based Liquid Biopsy Tests in Development: Information on emerging ctDNA tests.
- Market-Available CTC-based Liquid Biopsy Tests, 2021: A review of currently available CTC tests.
- Multi-Analyte Liquid Biopsy Tests, 2021: Highlights of tests assessing multiple analytes.
Clinical Applications and Benefits:
- Early Detection and Diagnosis: The role of liquid biopsy in early cancer detection and screening.
- Alternative Testing Methods: Use of liquid biopsy when tissue biopsy is challenging or impossible.
- Therapy Personalization and Monitoring: How molecular characterization through liquid biopsy aids in selecting and adjusting therapies.
- Disease Monitoring: The importance of liquid biopsy in observing disease progression, tumor evolution, residual disease, and early recurrence detection.
- Prognosis: Utilizing liquid biopsy for disease prognosis.
Table: Global Liquid Biopsy Market Forecast, by Region, 2021-2026 ($ millions)
| Region | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR ’21 – ’26 |
| North America | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Europe | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Asia Pacific | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Rest of World | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| WORLD | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
INTRODUCTION
LIQUID BIOPSY TECHNOLOGIES
INDUSTRY STRUCTURE
LIQUID BIOPSY MARKET REVENUES AND FORECAST
-
- Figure 1-1: Global Liquid Biopsy Market by Geographic Region, 2021 (%)
-
- Table 1-1: Global Liquid Biopsy Market Forecast, by Region ($ millions), 2021-2026
-
- Figure 1-2: Global Liquid Biopsy Market Forecast by Region $ millions), 2021-2026
CHAPTER 2: LIQUID BIOPSY TECHNOLOGIES
INTRODUCTION
-
- Table 2-1: Comparison of Tissue and Liquid Biopsy
CURRENT MAJOR LIQUID BIOPSY TECHNOLOGIES
-
- Table 2-2: Advantages and Limitations of Major Liquid Biopsy Technologies
CHAPTER 3: CIRCULATING TUMOR DNA (CTDNA) LIQUID BIOPSY
INTRODUCTION
ADVANTAGES AND LIMITATIONS OF CTDNA IN LIQUID BIOPSY
CURRENT CTDNA-BASED LIQUID BIOPSY TESTS
-
- Table 3-1: Selected Market-Available ctDNA-based Liquid Biopsy Tests, 2021
- Biocartis
- Biocept
- Biodesix
- CellMax Life
- Circulogene
- Diacarta
- Epigenomics
- Foundation Medicine (Roche)
- Guardant Health
- Inivata (Neogenomics)
- LungLife AI
- Myriad Genetics
- NeoGenomics
- OncoDNA
- Personal Genomic Diagnostics
- QIAGEN
- Resolution Biosciences
- Roche Diagnostics
- Sysmex-Inostics
- Tempus
CTDNA-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
-
- Table 3-2: Selected ctDNA-based Liquid Biopsy Tests in Development
- Exact Sciences
- Freenome
- GRAIL
- Neogenomics
CHAPTER 4: CIRCULATING TUMOR CELLS (CTCS) LIQUID BIOPSY
INTRODUCTION
CHALLENGES IN THE DEVELOPMENT OF CTC-BASED LIQUID BIOPSY TESTS
CTC-BASED LIQUID BIOPSY TESTS
-
- Table 4-1: Selected Market-Available CTC-based Liquid Biopsy Tests, 2021
- Adaptive Biotechnologies
- Biocept
- CellMax Life
- Epic Sciences
- GILUPI
- LungLife AI
- Menarini-Silicon Biosystems
- QIAGEN
CTC-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
-
- Table 4-2: Selected CTC-based Liquid Biopsy Tests in Development, 2021
- ANGLE
- Epic Sciences
- Liquid Biotech USA
CHAPTER 5: EXTRACELLULAR VESICLES AND OTHER LIQUID BIOPSY
INTRODUCTION
LIQUID BIOPSY TESTS BASED ON EXTRACELLULAR VESICLES / OTHER ANALYTES
-
- Table 5-1: Selected Market-Available Liquid Biopsy Tests based on Extracellular Vesicles / Other Analytes, 2021
- Aspira Women’s Health (formerly Vermillion)
- Biodesix
- Exosome Diagnostics
- Hologic
- MDxHealth
EXTRACELLULAR VESICLE/OTHER ANALYTE-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
-
- Table 5-2: Selected Extracellular Vesicle/Other Analyte-based Liquid Biopsy Tests in Development, 2021
- Circulogene
- OncoCyte
- Resolution Biosciences
- VolitionRx
CHAPTER 6: MULTI-ANALYTE LIQUID BIOPSY TESTS
INTRODUCTION
LIQUID BIOPSY TESTS BASED ON MULTIPLE ANALYTES
-
- Table 6-1: Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2021
- Biocept
- Biodesix
- Foundation Medicine (Roche)
- LungLife AI
- NeoGenomics
- OncoDNA
MULTIPLE ANALYTE-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
-
- Table 6-2: Selected Multi Analyte-based Liquid Biopsy Tests in Development, 2021
- Exact Sciences
- Freenome
- GRAIL
- LungLife AI
CHAPTER 7: LIQUID BIOPSY TESTS FOR RESEARCH USE ONLY
INTRODUCTION
LIQUID BIOPSY TESTS FOR RESEARCH USE ONLY
-
- Table 7-1: Selected Liquid Biopsy Tests for Research Use Only, 2021
- Agena Bioscience
- ANGLE
- DiaCarta
- Exosome Diagnostics
- Guardant Health
- Natera
- QIAGEN
CHAPTER 8: LIQUID BIOPSY INDUSTRY ANALYSIS
INTRODUCTION
TIERS OF COMPETITION
-
- Table 8-1: Selected Participants in the Liquid Biopsy Market, 2021
COMPETITIVE FACTORS
SIGNIFICANT MARKET TRENDS
-
- Table 8-2: Significant Trends in the Liquid Biopsy Market, 2021
- Personalized Medicine
- Increasing Global Life Expectancy
- New Liquid Biopsy Products
- Increasing Accessibility of Genetic Testing
- Regulatory Hurdles
- Third-Party Payor Coverage
- Demonstrated Clinical Utility
- Incidence Rates of Specific Cancers
COMPETITORS NO LONGER IN THE LIQUID BIOPSY MARKET
-
- Table 8-3: Summary of Companies That Have Exited the Liquid Biopsy Market
CHAPTER 9: LIQUID BIOPSY MARKET
MARKET OVERVIEW
-
- Figure 9-1: Global Liquid Biopsy Diagnostics Market Estimate by Analyte, 2021 (%)
-
- Figure 9-2: Global Liquid Biopsy Diagnostics Market Estimate by Region, 2021 (%)
-
- Figure 9-3: Global Liquid Biopsy Market Estimate by Type of Use, (Research Use, Clinical Diagnostics Use) 2018 (%)
MARKET FORECAST
-
- Table 9-1: Global Liquid Biopsy Market Forecast by Region – North America, Europe, Asia Pacific, Rest of World, World ($ millions), 2021-2026
-
- Figure 9-4: Global Liquid Biopsy Market Forecast by Region – North America, Europe, Asia Pacific, Rest of World ( $ millions), 2021-2026
CHAPTER 10: MARKET BY ANALYTE
CIRCULATING TUMOR DNA
- Market Overview
- Applications
- Technologies
- Specimens
- Revenue Forecast
- Table 10-1: Global Liquid Biopsy Market for ctDNA ($ millions), 2021-2026
CIRCULATING TUMOR CELLS
- Market Overview
- Applications
- Technologies
- Specimens
- Revenue Forecast
- Table 10-2: Global Liquid Biopsy Market for CTCs ($ millions), 2021-2026
EXTRACELLULAR VESICLES AND OTHER ANALYTES
- Market Overview
- Applications
- Technologies
- Specimens
- Revenue Forecast
- Table 10-3: Global Liquid Biopsy Market for Extracellular Vesicles ($ millions), 2021-2026
MULTIPLE ANALYTES
- Market Overview
- Revenue Forecast
- Table 10-4: Global Liquid Biopsy Market for Multiple Analytes ($ millions), 2018-2023
CHAPTER 11: MARKET BY APPLICATION
THERAPY GUIDANCE AND MONITORING
- Market Overview
- Revenue Forecast
- Table 11-1: Liquid Therapy for Therapy Guidance ($ millions), 2021-2026
DIAGNOSIS/SCREENING
- Market Overview
- Revenue Forecast
- Table 11-2: Global Liquid Biopsy Market for Diagnosis and Screening ($ millions), 2021-2026
DISEASE PROGNOSIS
- Market Overview
- Revenue Forecast
- Table 11-3: Global Liquid Biopsy Market for Disease Prognosis ($ millions), 2021-2026
CHAPTER 12: MARKET BY CANCER TYPE
BREAST CANCER
- Market Overview
- Revenue Forecast
- Table 12-1: Global Liquid Biopsy Market for Breast Cancer ($ millions), 2021-2026
COLORECTAL CANCER
- Market Overview
- Revenue Forecast
- Table 12-2: Global Liquid Biopsy Market for Colorectal Cancer ($ millions), 2021-2026
LUNG CANCER
- Market Overview
- Revenue Forecast
-
- Table 12-3: Global Liquid Biopsy Market for Lung Cancer ($ millions), 2021-2026
OVARIAN CANCER
- Market Overview
- Revenue Forecast
- Table 12-4: Global Liquid Biopsy Market for Ovarian Cancer ($ millions), 2021-2026
PROSTATE CANCER
- Market Overview
- Revenue Forecast
- Table 12-5: Global Liquid Biopsy Market for Prostate Cancer ($ millions), 2021-2026
OTHER CANCERS
- Market Overview
- Revenue Forecast
- Table 12-6: Global Liquid Biopsy Market for Other Cancers ($ millions), 2021-2026
Notes: *Including bladder, gastrointestinal, pancreatic, renal, melanoma and hematological malignancies.
PAN-CANCER TESTS
- Market Overview
- Revenue Forecast
- Table 12-7: Global Liquid Biopsy Market for Pan-Cancer Testing ($ millions), 2021-2026
CHAPTER 13: LIQUID BIOPSY COMPANY PROFILES
TOP TEN COMPANIES IN THE LIQUID BIOPSY MARKET
-
- Table 13-1
Top Ten Companies in the Liquid Biopsy Market
- ADAPTIVE BIOTECHNOLOGIES
- AGENA BIOSCIENCE, INC.
- ANGLE, PLC
- ASPIRA WOMEN’S HEALTH
- BIOCARTIS GROUP NV
- BIOCEPT, INC.
- BIODESIX
- CELLMAX LIFE
- CIRCULOGENE
- DIACARTA, INC.
- EPIC SCIENCES
- EPIGENOMICS AG
- EXACT SCIENCES
- EXOSOME DIAGNOSTICS, INC.
- FOUNDATION MEDICINE, INC. (ROCHE)
- FREENOME, INC.
- GILUPI GMBH
- GRAIL (ILLUMINA)
- GUARDANT HEALTH, INC.
- HOLOGIC
- LUNGLIFE AI (FORMERLY CYNVENIO BIOSYSTEMS)
- MDXHEALTH
- MENARINI-SILICON BIOSYSTEMS, SPA
- MYRIAD GENETICS, INC.
- NATERA, INC.
- NEOGENOMICS LABORATORIES, INC.
- ONCOCYTE CORPORATION
- ONCODNA S.A.
- ONCIMMUNE
- PERSONAL GENOME DIAGNOSTICS
- PREDICINEQ2 SOLUTIONSQIAGEN N.V.
- Cell-free DNA Technologies
- CTC Technologies
- Exosome and miRNA Technologies
- RESOLUTION BIOSCIENCES (AGILENT)
- ROCHE DIAGNOSTICS
- STAGEZERO LIFE SCIENCES
- SYSMEX-INOSTICS, INC.
- TEMPUS
- VERACYTE
- VOLITIONRX
Related products
IVD Market Trends Report, March 2023
March 17, 2023
Diagnostic testing remains a cornerstone in healthcare, aiding physicians in diagnosis and providing crucial information for treatments like precision medicine. As we navigate the aftermath of the COVID-19 pandemic, the IVD market is evolving, driven by new products, shifts in global health spending, regulatory updates, and changing disease trends. Despite these shifts, the IVD market…
Price range: $3,000.00 through $4,500.00
The Worldwide Market for Clinical Laboratory Services, 9th Edition
June 25, 2024
Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies…
Price range: $5,000.00 through $7,500.00
The IVD Market in South Korea, 2024
February 26, 2024
Gain valuable insights into South Korea’s in vitro diagnostics (IVD) market with Kalorama Information’s comprehensive report, The IVD Market in South Korea, 2024. We offer a detailed analysis of South Korea’s IVD revenues for 2023 and forecasts for 2028, segmented into key categories such as clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC),…
Price range: $5,000.00 through $7,875.00
